Despite this, BPC-157 products continue to be sold as research chemicals or dietary supplements, which are not subject to FDA regulatory oversight
Always consult with a healthcare professional before starting any new supplement or research product
Important: BPC-157 is an investigational synthetic peptide compound
TB-500, the 43-amino acid form of Thymosin Beta-4 originally isolated from bovine thymus, serves as the dominant G-actin sequestering protein in mammalian cells, orchestrating cytoskeletal dynamics that underlie cellular migration, tissue remodeling, and cardiovascular protection while activating integrin-linked kinase pathways essential for cell survival and repair
Ongoing Surveillance During Treatment Once peptide therapy is initiated, ongoing surveillance for malignancy should continue throughout the treatment period and potentially beyond, depending on treatment duration and individual risk factors
These peptides are under consideration for addition to the FDAs list of bulk substances that may be used by compounding pharmacies
